Leukemia Breakthrough: Phase III Trial Achieves “Exceptional” Results

Leukemia Breakthrough: Phase III Trial Achieves “Exceptional” Results

Personalized therapy enhances survival rates for patients with CLL leukemia. A phase III trial conducted by the University of Leeds discovered that personalized treatment for…

Read More

Check Also

Innovators to scramble for $1m investment prize at 2024 Africa Tech Festival

Burgeoning innovators across the continent are set to begin a scramble for the $1,000,000 investment …

Leave a Reply

Your email address will not be published. Required fields are marked *